No insider purchase over the last 90 days. The latest, by 삼오제약, was filed 13 Jul 2026.
Who traded when
BuySaleSince the insiders bought
- -39.1%Entry ₩1,544 · Close at T+365 ₩940
- -39.1%Entry ₩1,544 · Close at T+365 ₩940
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 6 sharesShareKRXDART:20261001000613
- 7 sharesShareKRXDART:20261001000615
- 7 sharesShareKRXDART:20261001000614
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 19,799,184 sharesShareKRXDART:20260710000716Canonical exit: 11 Oct 2026 (T+90)
- KRXDART:20260710000715
- 114,800 sharesKRXDART:20260710000705
- ●Executives0DART
- ●Executives0DART
- 7,314,524 sharesKRXDART:20250704000398Canonical exit: 25 Sept 2025 (T+90)
- ●Executives0DART
- 40,000 shares@ ₩1,419.0034.8% of flowShareKRXDART:20240109000109Canonical exit: 3 Apr 2024 (T+90)
- 40,000 shares@ ₩1,418.0034.8% of flowShareKRXDART:20240109000112Canonical exit: 3 Apr 2024 (T+90)
- ●Executives0DART
- 50,000 shares@ ₩2,007.0065.2% of flowShareKRXDART:20230213000245Canonical exit: 10 May 2023 (T+90)
- 50,000 shares@ ₩2,007.0065.2% of flowShareKRXDART:20230213000261Canonical exit: 10 May 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 26 declarations
About 아미노로직스
아미노로직스, a South Korean chemicals and materials company valued at KRW 86.9 billion, has 20 filings from 5 filers, published from March 8, 2021 to October 2, 2026. On February 9, 2023, 오장석 and 오성석, both representative directors (대표이사), each bought EUR 74,259: the two largest purchases on file. On January 4, 2024, two insiders again bought together, EUR 79,209 in all, including EUR 39,618 for 오장석.
In total there are 6 purchases (EUR 227,727 for the 4 that carry an amount, median EUR 56,939) against 4 sales with no amount, so 60% of open-market trades are purchases. 삼오제약, listed as a holder of 10% or more, has 4 filings (1 purchase, 2 sales), and 오라이언자산운용, a major holder, one purchase. The company itself, 아미노로직스, appears on 7 filings with no purchase or sale.
Read moreShow less
Ten filings are of another nature. Recorded trades run from February 9, 2023 to June 27, 2025; 8 filings from 2026 fall within the last twelve months, including 1 purchase and 4 sales. The median publication delay is 5 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations